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Background and objectives 
Thyroid cancer incidence has increased globally since the 1970s1. Numerous studies 
have confirmed this striking trend including studies from: the United states,2-5 
Puerto Rico,6 Canada,7 China,8,9 Saudi Arabia,10 Australia,11 France,12 Nordic 
countries,13 Portugal,14 Croatia,15 Slovak Republic,16 Great Britain as a whole17 and 
Scotland,18 Wales19 and England20 alone. Some authors have identified the trend as 
early as the 1960s.16,18 The importance of studying trends worldwide is evident from 
the results in the literature. We aimed to produce a detailed report of trends in 
Northern Ireland (NI) to expand on previous work including a report of all cancers 
in NI21 and the cancer statistics presented on the NI Cancer Registry (NICR) 
website annually (http://qub.ac.uk/research-centres/nicr/CancerInformation/). 
 
Methods 
A retrospective, descriptive epidemiological review was performed using 
anonymised data from the NICR. C73 is the thyroid cancer ICD-10 code. We used 
STATA to calculate incidence statistics and Joinpoint Regression Analysis22,23 to 
analyse trend significance. Registry ethical approval was previously granted.  
 
Results 
There were 1,212 cases over the 22 years (27.06% male, 72.94% female, 
F:M=2.7:1). Incidence increased significantly in females (1999-2014, annual 
percentage change (APC) +4.64%, p<0.05, 95% confidence interval (CI) +2.4, +6.9). 
Frequency increased predominantly in ages 40-64 (1995-2014, APC +4.66%, 
p<0.05, CI +2.5, +6.9). 55.63% of the 320 cases with staging data (2010-2014) were 
stage I. Papillary carcinoma frequency increased dramatically (2004-2014, APC 
+11.01%, p<0.05, CI +5.8, +16.4). 
 
Conclusions 
This study shows that thyroid cancer incidence has increased in NI in the last 2 
decades in females and middle-aged patients. This is shown to be mainly due to 
papillary carcinomas, potentially mostly stage I. These findings corroborate the 
findings in the literature.1,2,4-20 This data may support the hypothesis put forward in 
the literature4,7 that over-diagnosis, due to the advent and increased use of sensitive 
technologies such as ultrasound and fine needle aspiration, has resulted in apparent 
increasing trends in thyroid cancer incidence. 
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